Unknown

Dataset Information

0

Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.


ABSTRACT: Alzheimer's disease and Parkinson's disease are associated with the cerebral accumulation of beta-amyloid and alpha-synuclein, respectively. Some patients have clinical and pathological features of both diseases, raising the possibility of overlapping pathogenetic pathways. We generated transgenic (tg) mice with neuronal expression of human beta-amyloid peptides, alpha-synuclein, or both. The functional and morphological alterations in doubly tg mice resembled the Lewy-body variant of Alzheimer's disease. These mice had severe deficits in learning and memory, developed motor deficits before alpha-synuclein singly tg mice, and showed prominent age-dependent degeneration of cholinergic neurons and presynaptic terminals. They also had more alpha-synuclein-immunoreactive neuronal inclusions than alpha-synuclein singly tg mice. Ultrastructurally, some of these inclusions were fibrillar in doubly tg mice, whereas all inclusions were amorphous in alpha-synuclein singly tg mice. beta-Amyloid peptides promoted aggregation of alpha-synuclein in a cell-free system and intraneuronal accumulation of alpha-synuclein in cell culture. beta-Amyloid peptides may contribute to the development of Lewy-body diseases by promoting the aggregation of alpha-synuclein and exacerbating alpha-synuclein-dependent neuronal pathologies. Therefore, treatments that block the production or accumulation of beta-amyloid peptides could benefit a broader spectrum of disorders than previously anticipated.

SUBMITTER: Masliah E 

PROVIDER: S-EPMC59799 | BioStudies | 2001-01-01

REPOSITORIES: biostudies

Similar Datasets

2019-01-01 | S-EPMC6615698 | BioStudies
2019-01-01 | S-EPMC6526619 | BioStudies
1000-01-01 | S-EPMC1851868 | BioStudies
1000-01-01 | S-EPMC1472455 | BioStudies
2008-01-01 | S-EPMC2688400 | BioStudies
2019-01-01 | S-EPMC6937797 | BioStudies
2017-01-01 | S-EPMC5651433 | BioStudies
1000-01-01 | S-EPMC2671987 | BioStudies
1000-01-01 | S-EPMC2867864 | BioStudies
2007-01-01 | S-EPMC2244645 | BioStudies